Recent Quotes
My Watchlist
Indicators
Local Stocks
NewsOK Local Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

AC Immune S.A. (NQ: ACIU )

6.330 USD +0.300 (+4.98%)
Official Closing Price Updated: 7:50 PM EST, Jan 22, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about AC Immune S.A.

< Previous 1 2 3 Next >
AC Immune Receives Competitive Target ALS Foundation Grant to Accelerate the Development of Proprietary Phosphorylated TDP-43 Immuno-assay
From GlobeNewswire News Releases
Immunotherapy Pioneer Prof. Carl H. June Joins AC Immune’s Board of Directors
From GlobeNewswire News Releases
Neurologist and Psychiatrist Prof. Johannes Rolf Streffer, MD Joins AC Immune SA as Chief Medical Officer
From GlobeNewswire News Releases
AC Immune Reports Q3 2020 Financial Results and Provides Business Update
From GlobeNewswire News Releases
AC Immune to Provide Strategy and Pipeline Update During Jefferies Virtual London Healthcare Conference
To feature discussion of the Company’s world-leading therapeutic and diagnostic candidates targeting TDP-43 
From GlobeNewswire News Releases
AC Immune and WuXi Biologics Strengthen Strategic Partnership to Accelerate AC Immune’s Anti-TDP-43 Antibodies into Clinical Development
Strategic partnership reflects AC Immune’s growing expertise in monoclonal antibody development 
From GlobeNewswire News Releases
Oxurion NV appoints Tom Graney, CFA as Chief Financial Officer
From GlobeNewswire News Releases
Competitive EU Grant Supports Collaboration to Accelerate Development of AC Immune's First-in-Class TDP-43 Diagnostic Agent
From GlobeNewswire News Releases
AC Immune Reports Top Line Results from TAURIEL Phase 2 Trial Evaluating Semorinemab in Early Alzheimer’s Disease
From GlobeNewswire News Releases
AC Immune to Showcase Anti-Tau Portfolio at H.C. Wainwright 22nd Annual Global Investment Conference
From GlobeNewswire News Releases
AC Immune Reports Q2 2020 Financial Results and Provides Business Update
From GlobeNewswire News Releases
AC Immune Initiates IND-Enabling Studies for First-in-Class Antibody Targeting TDP-43 to Treat Neurodegeneration
From GlobeNewswire News Releases
AC Immune Wins Prestigious Award to Develop a “Game-Changing” Parkinson’s Diagnostic Tool
From GlobeNewswire News Releases
AC Immune Demonstrates Enhanced Performance of First-in-class Parkinson’s Diagnostic Agent
From GlobeNewswire News Releases
AC Immune to Present Advances in Two of the Company’s World Leading Programs at the Upcoming Alzheimer’s Association International Conference
Presentations to highlight the Company’s broad expertise addressing both novel and well-established targets in neurodegenerative diseases 
From GlobeNewswire News Releases
Thinking about buying stock in Tonix Pharmaceuticals, AC Immune, Ford Motor Company, J.Jill Inc, or InnerWorkings Inc?
InvestorsObserver issues critical PriceWatch Alerts for TNXP, ACIU, F, JILL, and INWK. 
From PR Newswire
24/7 Market News- Biotech Headlines
Tags healthcare/pharmaceuticals s:colorado business/economy
From EIN Presswire
AC Immune Advances phospho-Tau Alzheimer’s Vaccine in Phase 1b/2a Study
From GlobeNewswire News Releases
Tau-PET Tracer PI-2620 Could Set New Standards for an Improved Diagnosis of Progressive Supranuclear Palsy
Results published in JAMA Neurology demonstrate the potential for a best-in-class diagnostic tool 
From GlobeNewswire News Releases
AC Immune Announces Results of Annual General Meeting
From GlobeNewswire News Releases
AC Immune CEO to Showcase Novel Target Programs at UBS Global Healthcare Conference
From GlobeNewswire News Releases
AC Immune Reports Q1 2020 Financial Results and Provides Business Update
From GlobeNewswire News Releases
AC Immune Presents the Latest Preclinical Data on Novel Drug Targets for Neurodegenerative Diseases
From GlobeNewswire News Releases
AC Immune Reports Full-Year 2019 Financial Results and Provides 2020 R&D Outlook
From GlobeNewswire News Releases
AC Immune Receives Second Milestone and New Milestone to Increase the Potential Deal Value of Lilly Morphomer™ Tau Partnership
From GlobeNewswire News Releases
Internationally Renowned Neurologist Dr. Juan Fortea Joins AC Immune’s Clinical Advisory Board
Latest appointment further reinforces the depth and breadth of the Company’s clinical development competences in Down syndrome-related Alzheimer’s disease 
From GlobeNewswire News Releases
AC Immune to Present New Data Demonstrating the Depth of its Neurodegenerative Programs at the Upcoming Advances in Alzheimer’s and Parkinson’s Therapies Focus Meeting
Four presentations at AAT-AD/PD™ focus meeting 
From GlobeNewswire News Releases
AC Immune to Present at Jefferies 2019 London Healthcare Conference
From GlobeNewswire News Releases
AC Immune Q3 2019 Financial Results and Business Update
From GlobeNewswire News Releases
AC Immune Hosts Key Opinion Leader Event: ‘Untangling’ Tau Pathology to Treat Alzheimer’s and Neurodegenerative Diseases
From GlobeNewswire News Releases
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.